首页> 外文期刊>Vaccine >Embryo vaccination of chickens using a novel adjuvant formulation stimulates protective immunity against Eimeria maxima infection.
【24h】

Embryo vaccination of chickens using a novel adjuvant formulation stimulates protective immunity against Eimeria maxima infection.

机译:使用新的佐剂制剂对鸡进行胚胎疫苗接种可刺激针对最大艾美耳球虫感染的保护性免疫。

获取原文
获取原文并翻译 | 示例
           

摘要

Our previous study demonstrated that chickens immunized subcutaneously with an Eimeria recombinant profilin protein vaccine emulsified in a Quil A/cholesterol/DDA/Carbopol (QCDC) adjuvant developed partial protection against experimental avian coccidiosis compared with animals immunized with profilin alone. Because in ovo vaccination is presently used in commercial applications worldwide throughout the poultry industry, the current study was undertaken to investigate chicken embryo vaccination with profilin plus QCDC adjuvant. Eighteen day-old embryos were immunized with isotonic saline (control), profilin alone, QCDC alone, or profilin plus QCDC, and orally challenged with live Eimeria maxima at 7 days post-hatch. Body weight gain, fecal oocyst output, and intestinal cytokine transcript levels were assessed as measures of protective immunity. While immunization with profilin alone or QCDC alone did not alter body weight gain of infected chickens compared with the saline control group, vaccination with profilin plus QCDC increased body weight gain such that it was equal to the uninfected controls. Immunization with profilin plus QCDC also reduced fecal oocyst shedding compared with unimmunized controls, although in this case QCDC failed to provide an adjuvant effect since no difference was observed between the profilin-only and profilin/QCDC groups. Finally, increased levels of transcripts encoding IL-1 beta , IL-15, and IFN- gamma were seen in the intestinal tissues of animals given profilin plus QCDC compared with the profilin-only or QCDC-only groups. In summary, this study demonstrates an adjuvant effect of QCDC on body weight gain and intestinal cytokine responses following in ovo vaccination of chickens with an Eimeria profilin vaccine.Digital Object Identifier http://dx.doi.org/10.1016/j.vaccine.2010.09.051
机译:我们之前的研究表明,用Quil A /胆固醇/ DDA / Carbopol(QCDC)佐剂乳化的 Eimeria 重组profilin蛋白疫苗皮下免疫的鸡与用profilin免疫的动物相比,对实验性禽球虫病具有部分保护作用。单独。由于卵内疫苗接种目前在整个家禽业的全球商业应用中使用,因此进行了当前的研究,以研究用普罗菲林和QCDC佐剂进行的鸡胚疫苗接种。用等渗盐水(对照),单独的普罗菲林,单独的QCDC或普罗菲林加QCDC免疫18天大的胚胎,并在孵化后7天口服活的大艾美耳虫。体重增加,粪便卵囊输出和肠细胞因子转录水平被评估为保护性免疫的量度。尽管与生理盐水对照组相比,单独使用蛋白前列蛋白或单独进行QCDC免疫并没有改变感染鸡的体重增加,但使用蛋白前列蛋白加QCDC进行的疫苗接种却增加了体重增加,因此与未感染的对照组相同。与未免疫的对照组相比,使用蛋白原蛋白和QCDC的免疫也减少了粪卵囊的脱落,尽管在这种情况下QCDC无法提供佐剂作用,因为仅在蛋白原蛋白的患者和蛋白原/ QCDC组之间没有观察到差异。最后,与仅使用profilin或仅使用qcdc的组相比,在使用profilin加QCDC的动物的肠组织中发现了编码IL-1β,IL-15和IFN-γ的转录物水平增加。总而言之,这项研究证明了QCDC对用 Eimeria profilin疫苗进行鸡的卵内接种后对体重增加和肠道细胞因子应答的佐剂作用。数字对象标识符http://dx.doi.org /10.1016/j.vaccine.2010.09.051

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号